Marc brings over 25 years of pharmaceutical industry financial planning and analysis experience to Atea.
Prior joining Atea, Marc served as Director of Financial Planning and Analysis at Scholar Rock. Before that, he was Associate Director of Financial Planning and Analysis at Sunovion Pharmaceuticals. Earlier, Marc served as Global Program Finance Officer at Novartis and Associate Director of Financial Planning and Analysis at Idenix Pharmaceuticals.
Marc holds an MBA in Finance and Accounting from Boston College Carroll School of Management and a BA in Accounting from HoGent in Belgium.
Back to Full Team
Atea is a clinical-stage biopharmaceutical company committed to addressing unmet medical needs through novel antiviral treatments.
Copyright © 2023 By Atea Pharmaceuticals. All Rights Reserved. Privacy Policy | Terms of Use